Literature DB >> 30100377

CCR4-targeted therapy in cutaneous T-cell lymphoma.

Robert Gniadecki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30100377     DOI： 10.1016/S1470-2045(18)30449-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Invariant NKT Cells Promote the Development of Highly Cytotoxic Multipotent CXCR3+CCR4+CD8+ T Cells That Mediate Rapid Hepatocyte Allograft Rejection.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Sachi R Chaudhari; Jing Han; Chelsea M Peterson; Robert T Warren; Madison M Hart; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  J Immunol       Date:  2021-11-22       Impact factor: 5.426

2.  CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma.

Authors:  Yijian Zhang; Kai Chen; Li Li; Weidong Mao; Dong Shen; Ninghua Yao; Lei Zhang
Journal:  Ann Transl Med       Date:  2021-09

3.  Novel Therapeutic Targeting of CCL3-CCR4 Axis Mediated Apoptotic Intesitnal Injury in Necrotizing Enterocolitis.

Authors:  Xi Yuan; Zihan Xiong; Wei Liu; Yue Li; Hongdong Li; Xuemei Zhang; Yibing Yin; Pingyong Xu; Ju Cao; Dapeng Chen; Zhixin Song
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.